Plasma fat concentration increases in visceral fat obese men during high-intensity endurance exercise
Shigeharu Numao1, Yoichi Hayashi1, Yasutomi Katayama1
1Graduate School of Comprehensive Human Sciences, University of Tsukuba, Japan.
Summary:
The purpose of this study was to investigate differences in fat metabolism between visceral fat obese (VF-Ob) and abdominal subcutaneous obese (SF-Ob) men during "high-intensity endurance exercise". Fourteen obese (body mass index >25 kg/m(2)) men were classified into two groups according to visceral fat area using computed tomography; i.e., VF-Ob (n = 7; mean age, 52.0 ± 2.5 year) and SF-Ob (n = 7; mean age, 57.3 ± 2.8 year) groups. Plasma fat concentration and fat oxidation were measured at rest and during 60-min high-intensity (70% of peak oxygen uptake) stationary cycling exercise. Plasma concentrations of free fatty acid and glycerol were significantly higher (P ≤ 0.05) in VF-Ob men compared with SF-Ob men during endurance exercise. However, no significant difference was found in fat oxidation between VF-Ob and SF-Ob men (697 ± 135 and 661 ± 96 kJ/h, respectively) during high-intensity endurance exercise. These results suggest that obesity phenotype affects plasma fat concentration even during high-intensity exercise. It is likely that plasma fat concentrations in visceral fat obese men during high-intensity endurance exercise are more increased compared with during moderate-intensity endurance exercise. Despite the difference in plasma fat concentration, total fat oxidation was similar in the two obese phenotypes.:
Related Concept Videos
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity
Hypodermis
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion


